Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing’s disease: 12-month, Phase III pasireotide study

Findling, J.W., Fleseriu, M., Newell-Price, J. et al. (5 more authors) (2016) Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing’s disease: 12-month, Phase III pasireotide study. Endocrine, 54 (2). pp. 516-523. ISSN 1355-008X

Abstract

Metadata

Authors/Creators:
  • Findling, J.W.
  • Fleseriu, M.
  • Newell-Price, J.
  • Petersenn, S.
  • Pivonello, R.
  • Kandra, A.
  • Pedroncelli, A.M.
  • Biller, B.M.K.
Copyright, Publisher and Additional Information: © The Author(s) 2016. This article is published with open access at Springerlink.com
Keywords: Pasireotide; Cushing’s disease; Salivary cortisol; Urinary free cortisol
Dates:
  • Accepted: 29 April 2016
  • Published (online): 21 May 2016
  • 1 November 2016
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Human Metabolism (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 06 Jul 2016 09:33
Last Modified: 24 Nov 2016 16:53
Published Version: http://dx.doi.org/10.1007/s12020-016-0978-6
Status: Published
Publisher: Humana Press
Refereed: Yes
Identification Number: https://doi.org/10.1007/s12020-016-0978-6

Share / Export

Statistics